Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
- Authors:
- Laura Gnesotto
- Guido Mioso
- Mauro Alaibac
-
Affiliations: Dermatology Unit, Department of Medicine, University of Padova, I‑35128 Padova, Italy - Published online on: June 24, 2022 https://doi.org/10.3892/etm.2022.11463
- Article Number: 536
-
Copyright: © Gnesotto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Domènech E, Grífols JR, Akbar A and Dignass AU: Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective. World J Gastroenterol. 27:908–918. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T: Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders. J Dermatol. 45:943–950. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Hiraishi K, Kawahara K, Maruyama I and Kanzaki T: Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: Evidence that GCAP removes Mac-1-expressing neutrophils. Ther Apher Dial. 10:247–256. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Chen XL, Mao JW and Wang YD: Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future. World J Gastrointest Pathophysiol. 11:43–56. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cuadrado E: Granulocyte/monocyte apheresis as immunotherapic tool: Cellular adsorption and immune modulation. Autoimmun Rev. 8:292–296. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Hanai H, Takeda Y, Eberhardson M, Gruber R, Saniabadi AR, Winqvist O and Lofberg R: The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: A concise review. Clin Exp Immunol. 163:50–58. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa K, Kamikozuru K, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, et al: Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: Modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci. 52:2725–2731. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Nishise S, Abe Y, Nomura E, Sato T, Sasaki Y, Iwano D, Yoshizawa K, Yagi M, Sakuta K and Ueno Y: Effect of cellulose acetate beads on interleukin-23 release. Ther Apher Dial. 20:354–359. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Rodríguez-Lago I, Benítez JM, García-Sánchez V, Gutiérrez A, Sempere L, Ginard D, Barreiro-de Acosta M and Cabriada JL: Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view. Gastroenterol Hepatol. 41:423–431. 2018.PubMed/NCBI View Article : Google Scholar : (In English, Spanish). | |
|
Tominaga K, Nakano M, Hoshino M, Kanke K and Hiraishi H: Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone. BMC Gastroenterol. 13(41)2013.PubMed/NCBI View Article : Google Scholar | |
|
Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E and Badia X: Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective? Dig Liver Dis. 39:617–625. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Yoshino T, Nakase H, Matsuura M, Matsumura K, Honzawa Y, Fukuchi T, Watanabe K, Murano M, Tsujikawa T, Fukunaga K, et al: Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants. Digestion. 84:3–9. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Filosa A and Filosa G: Neutrophilic dermatoses: A broad spectrum of disease. G Ital Dermatol Venereol. 153:265–272. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Nelson CA, Stephen S, Ashchyan HJ, James WD, Micheletti RG and Rosenbach M: Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol. 79:987–1006. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Nestle FO, Kaplan DH and Barker J: Psoriasis. N Engl J Med. 61:496–509. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Krueger JG and Bowcock A: Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis. 64 (Suppl 2):ii30–ii36. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Shindo E, Shikano K, Kawazoe M, Yamamoto T, Kusunoki N, Hashimoto Y and Nanki T: A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus. Lupus. 28:1017–1020. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hoegler KM, John AM, Handler MZ and Schwartz RA: Generalized pustular psoriasis: A review and update on treatment. J Eur Acad Dermatol Venereol. 32:1645–1651. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, Kingo K, Smith C and Barker JN: ERASPEN Network. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 31:1792–1799. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Yoshii N, Yonezawa T, Kawabata H, Saruwatari H and Kanzaki T: Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol. 49:329–332. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Ohnishi H, Kadowaki T, Mizutani Y, Nishida E, Tobita R, Abe N, Yamaguchi Y, Eto H, Honma M, Kanekura T, et al: Genetic background and therapeutic response in generalized pustular psoriasis patients treated with granulocyte and monocyte adsorption apheresis. Eur J Dermatol. 28:108–11. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Sawada K, Ohdo M, Ino T, Nakamura T, Numata T, Shibata H, Sakou J, Kusada M and Hibi T: Safety and tolerability of nafamostat mesilate and heparin as anticoagulants in leukocytapheresis for ulcerative colitis: Post Hoc analysis of a large-scale, prospective, observational study. Ther Apher Dial. 20:197–204. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Shukuya R, Hasegawa T, Niwa Y, Okuma K and Ikeda S: Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis. J Dermatol. 38:1130–1134. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Sugiura K: The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J Dermatol Sci. 74:187–192. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Suzuki A, Haruna K, Mizuno Y, Kuwae Y, Ono Y, Okumura K, Negi O, Kon Y, Takeuchi K, Takamori K, et al: Successful treatment of three cases of generalized pustular psoriasis with granulocyte and monocyte adsorption apheresis. Ther Apher Dial. 16:445–448. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Mizutani Y, Fujii K, Kawamura M, Inoue M, Mizutani YH, Matsuyama K, Doi T, Nagaya S and Seishima M: Intensive granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis. J Dermatol. 47:1326–1329. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fujii A, Ohnishi H and Seishima M: Generalized pustular psoriasis with IL-36 Receptor antagonist mutation successfully treated with granulocyte and monocyte adsorption apheresis accompanied by reduced serum IL-6 level. Ther Apher Dial. 22:92–93. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Sakanoue M, Takeda K, Kawai K and Kanekura T: Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy. Ther Apher Dial. 17:477–483. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Ikeda S, Takahashi H, Suga Y, Eto H, Etoh T, Okuma K, Takahashi K, Kanbara T, Seishima M, Morita A, et al: Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. J Am Acad Dermatol. 68:609–617. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Fujii A, Fujii K and Seishima M: Generalized pustular psoriasis with CARD14 Variant c.526G>C (p.Asp176His) successfully treated with granulocyte and monocyte adsorption apheresis. Ther Apher Dial. 23:298–299. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Koike Y, Okubo M, Kiyohara T, Fukuchi R, Sato Y, Kuwatsuka S, Takeichi T, Akiyama M, Sugiura K and Utani A: Granulocyte and monocyte apheresis can control juvenile generalized pustular psoriasis with mutation of IL36RN. Br J Dermatol. 177:1732–1736. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Fujisawa T, Moriya C, Shibuya Y, Kanoh H and Seishima M: Combination therapy of infliximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis. Acta Derm Venereol. 93:364–365. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Tominaga C, Yamamoto M, Imai Y and Yamanishi K: A case of old age-onset generalized pustular psoriasis with a deficiency of IL-36RN (DITRA) treated by granulocyte and monocyte apheresis. Case Rep Dermatol. 7:29–35. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Fujisawa T, Murase K, Okumura Y, Kanoh H, Doi T, Yoshida S, Ogura S and Seishima M: Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis. Ther Apher Dial. 15:374–378. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Fujisawa T, Suzuki S, Mizutani Y, Doi T, Yoshida S, Ogura S and Seishima M: Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis: Therapeutic outcomes in three refractory patients. Ther Apher Dial. 19:336–341. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Furusawa K, Hasegawa T and Ikeda S: Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis. Ther Apher Dial. 16:379–380. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Mabuchi T, Manabe Y, Yamaoka H, Ota T, Kato M, Ikoma N, Kusakabe Y, Komaba H and Ozawa A: Case of generalized pustular psoriasis with end-stage renal disease successfully treated with granulocyte monocyte apheresis in combination with hemodialysis. J Dermatol. 41:521–524. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Seishima M, Mizutani Y, Shibuya Y, Nagasawa C and Aoki T: Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis. Ther Apher Dial. 12:13–18. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Sugiura K, Haruna K, Suga Y and Akiyama M: Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis. J Eur Acad Dermatol Venereol. 28:1835–1836. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen MC, Guenova E, Dissemond J, Shinkai K and Langan SM: Pyoderma gangrenosum. Nat Rev Dis Primers. 6(81)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ahronowitz I, Harp J and Shinkai K: Etiology and management of pyoderma gangrenosum: A comprehensive review. Am J Clin Dermatol. 13:191–211. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Alavi A, French LE, Davis MD, Brassard A and Kirsner RS: Pyoderma Gangrenosum: An update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 18:355–372. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Russo I, Miotto S, Colpo A, Marson P, Tison T, Ferrazzi A and Alaibac M: Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Int Wound J. 14:282–284. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Higashi Y, Ibusuki A, Baba N, Hatanaka M, Tada KI and Kanekura T: Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum. Ther Apher Dial. 26:450–455. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Ikeda K, Hamada T, Otsuka M and Iwatsuki K: Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis. Eur J Dermatol. 21:804–805. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Ohmori T, Yamagiwa A, Nakamura I, Nishikawa K and Saniabadi AR: Treatment of pyoderma gangrenosum associated with Crohn's disease. Am J Gastroenterol. 98:2101–2102. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Ishikawa H, Kumano T, Suzuki Y, Mabe K, Suzuki T, Momma S and Momma T: A case of successful treatment with granulocytapheresis (GCAP) for pyoderma gangrenosum complicating ulcerative colitis. Jap J Clin Dermatol. 58:1099–1101. 2004. | |
|
Yoneda K, Chino Y, Kamei K, Yamada T, Nagura K and You M: Four Cases of pyoderma gangrenosum associated with ulcerative colitis. Jap J Clin Dermatol. 59:263–266. 2005. | |
|
Yanaru-Fujisawa R, Matsumoto T, Nakamura S, Kochi S, Iida M, Kohda F, Hirahashi M, Yao T and Mibu R: Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: A case report. Inflamm Bowel Dis. 11:780–781. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Seishima M, Mizutani Y, Shibuya Y, Nagasawa C and Aoki T: Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Ther Apher Dial. 11:177–182. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Fujino Y, Suzuki Y, Kohama R, Omoya T, Kitazoe K, Nakamoto J, Aoki H, Yano M, Sikiji T and Satake N: A case of Pyoderma Gangrenosum successfully treated by granulocytapheresis and steroid therapy. Tokushima J Med. 30:29–32. 2008. | |
|
Kawakami T, Yamazaki M and Soma Y: Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Am J Gastroenterol. 104:2363–2364. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Doi R, Haga T, Fujita A, Saito C, Takeuchi S, Matsuoka A, Kawakami T, Soma Y and Kouro T: Rinsho Derma. 52:585–587. 2010. | |
|
Kobayashi S, Takeshita T and Furue M: A case of Pyoderma Gangrenosum with Ulcerative Colitis successfully treated with Granulocytapheresis, Skin grafting and Steroid therapy. Nishi Nihon Hifuka. 73:474–477. 2011. | |
|
Ohno M, Koyama S, Ohara M, Shimamoto K, Kobayashi Y, Nakamura F, Mitsuru K and Andoh A: Pyoderma gangrenosum with ulcerative colitis successfully treated by the combination of granulocyte and monocyte adsorption apheresis and corticosteroids. Intern Med. 55:25–30. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Okada M, Okawa T, Takashima R and Higashiyama M: A case of successful treatment with granulocytapheresis for pyoderma gangrenosum complicating ulcerative colitis. Skin Research. 16:150–154. 2017. | |
|
Yamashita A, Nakayama C, Tashiro J and Miwa J: Ulcerative colitis accompanied by pyoderma gangrenosum successfully treated with granulocyte monocyte apheresis: A case report. Prog Dig Endosc. 90:130–131. 2017. | |
|
Tominaga K, Kamimura K, Sato H, Ko M, Kawata Y, Mizusawa T, Yokoyama J and Terai S: Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status. World J Clin Cases. 8:2092–2101. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shibuya T, Haga K, Saeki M, Haraikawa M, Tsuchihashi H, Okahara K, Nomura O, Fukushima H, Murakami T, Ishikawa D, et al: Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis. J Clin Apher. 35:488–492. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Kawahara K, Maruyama I and Kanzaki T: Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Ther Apher Dial. 9:292–296. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Maruyama I and Kanzaki T: Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol. 47:320–321. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Kawai M, Kawanami C, Fukuda A and Seno H: Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids. Clin J Gastroenterol. 14:1561–1566. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Murakami M and Terui T: Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism. J Dermatol Sci. 98:13–19. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mrowietz U, Bachelez H, Burden AD, Rissler M, Sieder C, Orsenigo R and Chaouche-Teyara K: Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study. J Am Acad Dermatol. 80:1344–1352. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Fujisawa T, Tawada C, Mizutani Y, Doi T, Yoshida S, Ogura S and Seishima M: Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis. Ther Apher Dial. 18:238–243. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kawakami H, Nagaoka Y, Hirano H, Matsumoto Y, Abe N, Tsuboi R, Kanno Y and Okubo Y: Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis. J Dermatol. 46:144–148. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Kawabata H, Maruyama I and Kanzaki T: Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol. 50:242–246. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Bulur I and Onder M: Behçet disease: New aspects. Clin Dermatol. 35:421–434. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Tong B, Liu X, Xiao J and Su G: Immunopathogenesis of Behcet's Disease. Front Immunol. 10(665)2019.PubMed/NCBI View Article : Google Scholar | |
|
Alpsoy E, Zouboulis CC and Ehrlich GE: Mucocutaneous lesions of Behcet's disease. Yonsei Med J. 48:573–585. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Higashi Y, Shimokawa M, Kawai K and Kanekura T: Granulocyte and monocyte adsorption apheresis for Behçet's disease in a pregnant woman. J Dermatol. 40:1042–1044. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Gushi A, Iwata M, Fukumaru S, Sakamoto R, Kawahara K, Maruyama I and Kanzaki T: Treatment of Behçet's disease with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol. 51 (2 Suppl):S83–S87. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Villarreal-Villarreal CD, Ocampo-Candiani J and Villarreal-Martínez A: Sweet Syndrome: A review and update. Actas Dermosifiliogr. 107:369–378. 2016.PubMed/NCBI View Article : Google Scholar : (In English, Spanish). | |
|
Cohen PR: Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2(34)2007.PubMed/NCBI View Article : Google Scholar | |
|
Fujii A, Mizutani Y, Hattori Y, Takahashi T, Ohnishi H, Yoshida S and Seishima M: Sweet's syndrome successfully treated with granulocyte and monocyte adsorption apheresis. Case Rep Dermatol. 9:13–18. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gerfaud-Valentin M, Jamilloux Y, Iwaz J and Sève P: Adult-onset Still's disease. Autoimmun Rev. 13:708–722. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Giacomelli R, Ruscitti P and Shoenfeld Y: A comprehensive review on adult onset Still's disease. J Autoimmun. 93:24–26. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Terasaki K, Higashi Y, Yoshii N, Kawahara K, Maruyama I and Kanzaki T: Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis. Clin Exp Dermatol. 29:410–412. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Iwasaki A, Kawakami H and Okubo Y: Granulocyte/Monocyte adsorption apheresis as a novel therapeutic approach in the treatment of an impetigo herpetiformis case. Ther Apher Dial. 22:414–416. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Namazi N and Dadkhahfar S: Impetigo herpetiformis: Review of pathogenesis, complication, and treatment. Dermatol Res Pract. 2018(5801280)2018.PubMed/NCBI View Article : Google Scholar | |
|
Fujii K, Takahashi T, Matsuyama K, Fujii A, Mizutani Y, Ohnishi H and Seishima M: Impetigo herpetiformis with a CARD14 Thr79Ile variant successfully treated with granulocyte and monocyte adsorption apheresis. J Dermatol. 47:e84–e85. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Saito-Sasaki N, Izu K, Sawada Y, Hino R, Nakano R, Shimajiri S, Nishimura I, Nakamura H, Sugiura K and Nakamura M: Impetigo herpetiformis complicated with intrauterine growth restriction treated successfully with granulocyte and monocyte apheresis. Acta Derm Venereol. 97:410–411. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Selmi C and Gershwin ME: Diagnosis and classification of reactive arthritis. Autoimmun Rev. 13:546–549. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wu IB and Schwartz RA: Reiter's syndrome: the classic triad and more. J Am Acad Dermatol. 59:113–121. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Yoshifuku A, Oyama K, Ibusuki A, Kawasaki M, Sakanoue M, Matsushita S, Kawai K, Kawahara K, Maruyama I and Kanekura T: Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease. Clin Exp Dermatol. 37:241–244. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Braun-Falco M, Kovnerystyy O, Lohse P and Ruzicka T: Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 66:409–415. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cugno M, Borghi A and Marzano AV: PAPA, PASH and PAPASH Syndromes: Pathophysiology, presentation and treatment. Am J Clin Dermatol. 18:555–562. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hatanaka M, Fujii K and Kanekura T: Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis. J Dermatol. 48:376–377. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Mizutani Y, Okano T, Takahashi T, Ohnishi H, Ohara O, Sano A and Seishima M: Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome treated with granulocyte and monocyte adsorption apheresis. Acta Derm Venereol. 97:275–276. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Tosca N and Stratigos JD: Possible pathogenetic mechanisms in allergic cutaneous vasculitis. Int J Dermatol. 27:291–296. 1988.PubMed/NCBI View Article : Google Scholar | |
|
Chen KR and Carlson JA: Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 9:71–92. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Goeser MR, Laniosz V and Wetter DA: A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am J Clin Dermatol. 15:299–306. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Yoshii N, Kawahara K, Maruyama I and Kanzaki T: Granulocyte and monocyte adsorption apheresis for cutaneous allergic vasculitis. Ther Apher Dial. 10:287–290. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Kiriakidou M and Ching CL: Systemic lupus erythematosus. Ann Intern Med. 172:ITC81–ITC96. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fortuna G and Brennan MT: Systemic lupus erythematosus: Epidemiology, pathophysiology, manifestations, and management. Dent Clin North Am. 57:631–655. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Kanekura T, Hashiguchi T, Mera Y, Katahira A, Nakamura I, Maruyama I and Kanzaki T: Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis. Dermatology. 208:79–80. 2004.PubMed/NCBI View Article : Google Scholar |
